141 related articles for article (PubMed ID: 34524257)
1. Cardiotoxic Effects of the Antineoplastic Doxorubicin in a Model of Metabolic Syndrome: Oxidative Stress and Transporter Expression in the Heart.
Ogonowski N; Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR; Fellet A; Balaszczuk AM; Celuch SM
J Cardiovasc Pharmacol; 2021 Dec; 78(6):784-791. PubMed ID: 34524257
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib.
Zhou ZY; Wan LL; Yang QJ; Han YL; Li Y; Yu Q; Guo C; Li X
Toxicol Appl Pharmacol; 2013 Oct; 272(1):238-44. PubMed ID: 23770382
[TBL] [Abstract][Full Text] [Related]
3. A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats.
Sonawane VK; Mahajan UB; Shinde SD; Chatterjee S; Chaudhari SS; Bhangale HA; Ojha S; Goyal SN; Kundu CN; Patil CR
Cardiovasc Toxicol; 2018 Oct; 18(5):459-470. PubMed ID: 29779119
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Thiamine Hydrochloride on Cardiac Function, Redox Status and Morphometric Alterations in Doxorubicin-Treated Rats.
Radonjic T; Rankovic M; Ravic M; Zivkovic V; Srejovic I; Jeremic J; Jeremic N; Sretenovic J; Matic S; Jakovljevic V; Nikolic Turnic T
Cardiovasc Toxicol; 2020 Apr; 20(2):111-120. PubMed ID: 31270735
[TBL] [Abstract][Full Text] [Related]
5. Acute exercise protects against doxorubicin cardiotoxicity.
Wonders KY; Hydock DS; Schneider CM; Hayward R
Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
[TBL] [Abstract][Full Text] [Related]
6. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
[TBL] [Abstract][Full Text] [Related]
7. Resistance training improves cardiac function and cardiovascular autonomic control in doxorubicin-induced cardiotoxicity.
Feitosa LAS; Carvalho JDS; Dantas CO; de Souza DS; de Vasconcelos CML; Miguel-Dos-Santos R; Lauton-Santos S; Quíntans-Júnior LJ; Santos MRV; de Santana-Filho VJ; Barreto AS
Cardiovasc Toxicol; 2021 May; 21(5):365-374. PubMed ID: 33387253
[TBL] [Abstract][Full Text] [Related]
8. Nilotinib reverses ABCB1/P-glycoprotein-mediated multidrug resistance but increases cardiotoxicity of doxorubicin in a MDR xenograft model.
Zhou ZY; Wan LL; Yang QJ; Han YL; Li D; Lu J; Guo C
Toxicol Lett; 2016 Sep; 259():124-132. PubMed ID: 27491883
[TBL] [Abstract][Full Text] [Related]
9. Effects of Resistance Exercise Training on Doxorubicin-Induced Cardiotoxicity.
Pfannenstiel K; Hayward R
J Cardiovasc Pharmacol; 2018 Jun; 71(6):332-339. PubMed ID: 29521673
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
[TBL] [Abstract][Full Text] [Related]
12. Concomitant low-dose doxorubicin treatment and exercise.
Sturgeon K; Schadler K; Muthukumaran G; Ding D; Bajulaiye A; Thomas NJ; Ferrari V; Ryeom S; Libonati JR
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R685-92. PubMed ID: 25009215
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
[TBL] [Abstract][Full Text] [Related]
14. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
[TBL] [Abstract][Full Text] [Related]
15. Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity.
Ferreira A; Cunha-Oliveira T; Simões RF; Carvalho FS; Burgeiro A; Nordgren K; Wallace KB; Oliveira PJ
Toxicology; 2017 Sep; 390():63-73. PubMed ID: 28865727
[TBL] [Abstract][Full Text] [Related]
16. Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na
Liu X; Qiu Y; Huang N; Liu YH; Wang HH; Yu YN; Song YT; Wan GR; Wang SX; Li P; Yin YL
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22971. PubMed ID: 34813134
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin Significantly Prevents the Doxorubicin-induced Acute Cardiotoxicity via Non-antioxidant Pathways.
Barış VÖ; Dinçsoy AB; Gedikli E; Zırh S; Müftüoğlu S; Erdem A
Cardiovasc Toxicol; 2021 Sep; 21(9):747-758. PubMed ID: 34089496
[TBL] [Abstract][Full Text] [Related]
18. Protective role of CoQ10 or L-carnitine on the integrity of the myocardium in doxorubicin induced toxicity.
Mustafa HN; Hegazy GA; Awdan SAE; AbdelBaset M
Tissue Cell; 2017 Jun; 49(3):410-426. PubMed ID: 28410798
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats.
Xu M; Sheng L; Zhu X; Zeng S; Chi D; Zhang GJ
Tumori; 2010; 96(3):460-4. PubMed ID: 20845809
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid B attenuates doxorubicin-induced ER stress by inhibiting TRPC3 and TRPC6 mediated Ca
Chen RC; Sun GB; Ye JX; Wang J; Zhang MD; Sun XB
Toxicol Lett; 2017 Jul; 276():21-30. PubMed ID: 28495616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
